Welcome to our dedicated page for PCT news (Ticker: PCTL), a resource for investors and traders seeking the latest updates and insights on PCT stock.
PCT LTD (PCTL) is a company that operates through its subsidiary, Paradigm Convergence Technologies Corp, specializing in manufacturing, selling, and leasing equipment that produces EPA approved, eco-friendly disinfectant and degreaser fluids. Recently, PCTL announced its partnership with HypoClean, LLC, a Colorado corporation focusing on hypochlorous acid (HOCl) technology, and Veteran Commercial Cleaning, LCC, a global commercial cleaning and supply company that is serviced disabled veteran and minority-owned.
PCT LTD (OTCPK: PCTL) announces its strategic partnership with ACE Janitorial, successfully transitioning a major Boston Healthcare system from Hydrolyte® to the Annihilyzer system. The conversion involves deploying two Annihilyzer LV-1 Generators, four SMART Carts, and four SMART handheld sprayers. This move is seen as a foundation for further expansion into the New England healthcare market. PCTL, focused on sustainable cleaning technologies, aims to broaden its market share and has applied for OTC QB listing.
PCT LTD (OTCPK: PCTL) is focused on sustainable disinfecting and cleaning technologies. The company has appointed Craig Fischer as its new IR/PR team leader, aiming to enhance sales and distribution efforts. Fischer brings over 20 years of experience in public relations and will manage global communications. CEO Gary J. Grieco expressed optimism about Fischer's ability to scale operations. PCTL is currently trading on OTC: PINK and has applied for a listing on the OTC QB market, seeking to expand its market presence in the U.S. and U.K.
PCT LTD (OTC Pink: PCTL) recently completed a 14-day oil stimulation test on four wells, significantly improving oil production. Initially yielding just 1% oil, the stimulation process raised the average oil cut to 14.5%, translating to 14.4 barrels of oil worth approximately $864. The company plans another test in January 2022 using a newly developed Catholyte generator, expecting further enhancements in production efficiency. PCTL focuses on developing sustainable cleaning technologies and has future growth plans contingent on successful testing and funding.
PCT LTD (OTC Pink: PCTL) announces the development of an innovative 8 cell Gen 2 generator, doubling the capacity of its previous model while maintaining the same footprint. This advancement is expected to boost profits by reducing production costs. The company is also expanding into the oil and gas sector with the new generator and NanoGas™ Technologies, enhancing its environmental biocide solution, Nano-Hydrolyte™. Additionally, a new Catholyte generator aims for a 50-100% increase in production. CEO Gary Grieco emphasizes the benefits of producing in-house, aligning quality with higher concentration.
PCT LTD (OTC Pink: PCTL) has announced the restructuring of a $1,465,000 note with RB Capital Partners, extending the due date to December 15, 2024 at a 5% interest rate. The note is convertible to common stock above market value at $0.07. CEO Gary Grieco highlighted this funding's significance, enabling the company to repay existing debts, expand its workforce, and enhance product offerings. Additionally, a recent $2,250,000 equity investment from Krag Capital aims to bolster PCTL's market presence across the healthcare and agricultural sectors.
PCT LTD (PCTL) announced a private placement of $2,250,000 led by Krag Capital's CEO Mike Sims. The placement involved 1,500,000 shares of Series C Convertible Preferred Stock priced at $1.50 each, convertible to common stock at $0.015. Proceeds will be used to reduce debt and purchase materials for new hospital units. This investment reflects confidence in PCTL's potential for growth, as highlighted by CEO Gary Grieco. Additionally, the partnership with Krag Capital aims to enhance PCTL's marketing and branding efforts.
PCT Ltd (OTC Pink: PCTL) has announced a collaboration with Nano Gas™ Technologies on a patent-pending eco-friendly technology for the oil and gas sector. Independent testing in Houston showed significant improvements in the water to oil ratio (WOR), achieving a 20% increase in oil recovery efficiency using Nano-Catholyte™. The new product line includes Nano-Catholyte™ and Nano-Hydrolyte™, both aiming to reduce environmental impact while enhancing oil recovery. Maverick Energy Services is already seeing cost savings with Nano-Catholyte™ in their operations.
PCT LTD (PCTL) announces promising results from an independent lab in Denver, confirming a 95% reduction in E. coli using its new solid form of hypochlorous acid (HOCl). This milestone suggests a viable crystallization and rehydration process, reinforcing the scientific basis for its product. CEO Gary Grieco highlights the breakthrough's potential impact on healthcare and oil & gas sectors. Future efforts will focus on analyzing crystal structures and conducting EPA studies to commercialize the product, marking a significant step in PCTL's innovative technology journey.
PCT LTD (PCTL) has announced a patent pending technology combining electrochemically activated solutions with nanobubble dispersions to enhance biocidal properties. This innovation targets corrosive bacteria in the oilfield and aims to improve oil recovery from fractured reservoirs. Currently undergoing field trials in Southwest Missouri, Oklahoma, and Texas, the company plans to validate this technology further. A detailed report is set for release on November 17, 2021. CEO Gary Grieco highlighted the extensive lab and field testing conducted over nine months to support this patent filing.
PCT LTD (PCTL) has acquired rights to a novel delivery technology from Colorado-based Onza Corporation. This patent-pending technology allows PCT to convert hypochlorous acid into a dry crystal, simplifying shipping and extending shelf life significantly. The technology enhances cost-effectiveness and expands potential applications for unstable compounds like chlorine dioxide. PCT has secured exclusive rights for using crystallized hypochlorous acid and medical applications for crystallized chlorine dioxide, with market studies and cost analyses underway.